anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Nuvalent · conference-presentation

Nuvalent | Investor Presentation Deck | 31 slides

31 pages · 3 arc beats · 1 loops

Conference-Presentation Download JSON
Unlock

Nuvalent | Investor Presentation Deck | 31 slides

Nuvalent · 2022-10
arc beats above · slides in the middle · loops below · scroll → 1 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON
Narrative range 3 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 8 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Solution 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Market Size 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides
— 0/1 slides

Slide inventory

31
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
front_matter
Open slide detail
03
The slide uses a clean, minimalist layout with a network-style background graphic.establish_context
Open slide detail
04
Includes a molecular visualization of the inhibitor binding to the protein.front_matter
Open slide detail
05
The slide uses a matrix-like structure to compare drug capabilities against specific clinical requirements.compare_peers
Open slide detail
06
The slide uses a human anatomy diagram to map specific TRK receptor inhibition (TRKB, TRKC, TRKA) to associated clinical side effects.diagnose_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
07
The slide uses a list of icons to represent key clinical attributes of the drug candidate.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
08
The slide uses dot plots for IC50 values and a bar chart for tumor regression, highlighting NVL-520's performance.analyze_data
Open slide detailLoop · Cost Of Inaction
09
The chart on the right uses a logarithmic scale for the Selectivity Index.analyze_data
Open slide detailLoop · Cost Of Inaction
10
Includes list of authors and their institutional affiliations.front_matter
Open slide detailLoop · Cost Of Inaction
11
The slide outlines the clinical trial structure, including patient eligibility criteria and study objectives for both phases.present_framework
Open slide detailLoop · Cost Of Inaction
12
The slide uses a process-flow style diagram to show how initial cohorts are expanded via back-filling and then filtered into a response-evaluable population.analyze_data
Open slide detailLoop · Cost Of Inaction
13
The slide presents baseline patient characteristics and prior treatment history for a clinical trial cohort.analyze_data
Open slide detailLoop · Cost Of Inaction
14
Data presented at ENA 2022. N=35 patients.analyze_data
Open slide detailLoop · Cost Of Inaction
15
The chart displays a log-scale y-axis for concentration. The data supports once-daily (QD) dosing based on a 20h half-life.analyze_data
Open slide detailLoop · Cost Of Inaction
16
Clinical trial data presentation for ENA 2022.analyze_data
Open slide detailLoop · Cost Of Inaction
17
The chart is a classic waterfall plot used in oncology clinical trials to demonstrate drug efficacy.analyze_data
Open slide detail
18
The chart is a swimmer plot (often used in oncology to show duration of response/treatment).analyze_data
Open slide detail
19
Includes a spider plot (waterfall-like over time) and a bar chart showing allele clearance.analyze_data
Open slide detail
20
The slide uses a before-after-during progression (Baseline, 4 weeks, 8 weeks) to visualize drug efficacy.illustrate_case
Open slide detail
21
The slide uses a timeline-style list on the left to describe the patient's treatment history and a before-after image grid on the right to show clinical responsillustrate_case
Open slide detail
22
Slide 22 of a conference presentation.summarize
Open slide detail
23
transition
Open slide detail
24
The slide uses a Gantt-style timeline to represent drug development stages.plan_implementation
Open slide detailBeat · Market Size
25
present_solution
Open slide detail
26
The slide uses a combination of scatter plots, bar charts, and a waterfall-style selectivity chart to demonstrate drug efficacy and safety profile.analyze_data
Open slide detail
27
The slide compares vehicle control vs NVL-655 treatment across multiple cell lines and a patient-derived xenograft (PDX) model.analyze_data
Open slide detail
28
The slide uses a structured table to define patient eligibility criteria for different cohorts in a clinical trial.analyze_data
Open slide detail
29
present_solution
Open slide detail
30
The slide uses three distinct chart types to demonstrate drug efficacy and safety profile.summarize
Open slide detail
31
Slide 31 of a corporate presentation.summarize
Open slide detail